Prevalence of Diseases in Pilgrims Referring to Iranian Clinics in Iraq

Document Type : Brief Report


1 Zanjan Blood Transfusion Center, Zanjan University of Medical Sciences, Zanjan, IR Iran

2 Zanjan University of Medical Sciences, Zanjan, IR Iran


Introduction: Every year a large number of Muslims, especially from Iran, travel to holy places in Iraq for pilgrimage. Like Hajj and other mass gatherings, the health of pilgrims in Iraq is a major issue. This study aimed to determine the prevalence of diseases in pilgrims referring to Iranian clinics in Iraq.
Methods: This descriptive study was conducted in April and May, 2013. All Iranian pilgrims referring to clinics in Najaf, Karbala, Baghdad, or Kazmain during this one-month period were entered in the study. Data was gathered from medical records in these clinics and analyzed using SPSS software version 16.
Results: From 22 April to 20 May, 2013, a total of 26,574 patients were admitted to Iranian clinics in Iraq, 42% of whom were women and 58% were men. The main causes for referring to the clinics were signs and symptoms of acute respiratory infection (48%), musculoskeletal problems (19%), control of underlying disease (diabetes, cardiovascular disease, hypertension, gastritis) (16%), and gastroenteritis (7%). The prevalence of underlying conditions was higher in women.
Conclusion: According to the survey results and specific conditions in terms of climate and the infrastructure of facilities in Iraq, it seems that infectious and communicable diseases can be prevented by providing appropriate training prior to the pilgrimage and emphasizing and monitoring the use of personal protective equipment. Moreover, vaccination, medical examination before deployment, and establishing medical records can be better ways to treat underlying diseases, control health, and ensure the better health of pilgrims.


  1. Memish ZA. The Hajj: communicable and non-communicable health hazards and current guidance for pilgrims. Euro Surveill. 2010;15(39):19671.
  2. Haworth E, Barasheed O, Memish ZA, Rashid H, Booy R. Prevention of influenza at Hajj: applications for mass gatherings. J R Soc Med. 2013;106(6):215-23.
  3. Khan K, Memish ZA, Chabbra A, Liauw J, Hu W, Janes DA, et al. Global public health implications of a mass gathering in Mecca, Saudi Arabia during the midst of an influenza pandemic. J Travel Med. 2010;17(2):75-81.
  4. Memish ZA, Zumla A, Alhakeem RF, Assiri A, Turkestani A, Al Harby KD, et al. Hajj: infectious disease surveillance and control. Lancet. 2014;383(9934):2073-82.
  5. Meysamie A, Ardakani HZ, Razavi SM, Doroodi T. Comparison of mortality and morbidity rates among Iranian pilgrims in Hajj 2004 and 2005. Saudi Med J. 2006;27(7):1049-53.
  6. Gautret P, Yong W, Soula G, Gaudart J, Delmont J, Dia A, et al. Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2009;15(4):335-40.
  7. Gautret P, Soula G, Delmont J, Parola P, Brouqui P. Common health hazards in French pilgrims during the Hajj of 2007: a prospective cohort study. J Travel Med. 2009;16(6):377-81.
  8. Choudhry AJ, Al-Mudaimegh KS, Turkistani AM, Al-Hamdan NA. Hajj-associated acute respiratory infection among hajjis from Riyadh. East Mediterr Health J. 2006;12(3-4):300-9.
  9. Alfelali M, Barasheed O, Tashani M, Azeem MI, El Bashir H, Memish ZA, et al. Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: A 10-year retrospective analysis of data. Vaccine. 2015;33(22):2562-9.
  10. Barasheed O, Rashid H, Heron L, Ridda I, Haworth E, Nguyen-Van-Tam J, et al. Influenza vaccination among Australian Hajj pilgrims: uptake, attitudes, and barriers. J Travel Med. 2014;21(6):384-90.
  11. Gautret P, Benkouiten S, Sridhar S, Al-Tawfiq JA, Memish ZA. Diarrhea at the Hajj and Umrah. Travel Med Infect Dis. 2015;13(2):159-66.